The metagenomics sequencing market has been significantly growing with an increase in demand for drug discovery, clinical diagnostics, and the growing prevalence of genetic disorders. Further, the increase in advancements regarding DNA sequencing and the rise in the extension of metagenomics sequencing applications boost the growth of the global metagenomics sequencing market. In addition, developing countries also offer lucrative opportunities for metagenomics sequencing product manufacturers. The sample processing and library preparation hold the maximum share in the market attributed mainly to the growing number of metagenome sequencing research projects being conducted, the availability of technologically advanced and robust sample processing and library preparation assay kits, and the demand for efficient library preparation products.
Within the report, the market is segmented into product and service, workflow, technology, application, and geography. By product and service, the market is further segmented into reagents and consumables, instruments, services, and analysis and data interpretation solutions. On the basis of workflow, the market is segmented into sample processing and library preparation, sequencing, and data processing and analysis. By technology, the market is categorized into 16s rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing and de-novo assembly, and metatranscriptomics. Based on application, the market is divided into drug discovery, ecological and environmental applications, clinical diagnostics, soil microbiome applications, industrial applications, veterinary applications, and other applications. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
Metagenomic is a research field involving genomic analysis of microbial DNA from environmental communities. Metagenomic sequencing techniques enable researchers to analyze genes in the given sample. The method also allows for the assessment of microbial diversity and identifying the presence of microbes in various environments. Various steps are involved in metagenomics sequencing, including DNA extraction, library preparation, sequencing, assembly, annotation, and statistical analysis.
The rapid technological advancements in sequencers have enabled the advent of an efficient, portable, and easy-to-use NGS platform, which can provide a fast and accurate result. The introduction of such advanced technologies provides a competitive edge to the market players; as a result, several companies are increasingly adopting strategic alliances to maintain a strong position in the market.
Recent advancements in sequencing have allowed the genomes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), to be sequenced within hours or days of a case being identified. The novel metagenomic sequencing is critical to the detection and description of the novel pathogen. Early sharing of SARS-CoV-2 genome sequences allowed molecular diagnostic assays to be designed rapidly, enhancing global preparedness.
The metagenomics sequencing market has undergone several significant developments, and a few of these have been mentioned below:
Several players drive the metagenomics sequencing market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. BGI Genomics Co., Ltd., Eurofins Genomics, Illumina, Inc., Macrogen Inc., Oxford Nanopore Technologies Ltd, Pacific Biosciences of California, Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc., and Thermo Fisher Scientific Inc. is among the prominent players operating in the market.
In this report, the market has been segmented on the basis of: